Logotype for Jiangsu Yangnong Chemical Co Ltd

Jiangsu Yangnong Chemical (600486) H2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Jiangsu Yangnong Chemical Co Ltd

H2 2024 earnings summary

22 Dec, 2025

Executive summary

  • Revenue declined 9.09% year-over-year to ¥10.43 billion due to significant product price drops, with net profit attributable to shareholders down 23.19% to ¥1.20 billion.

  • The company maintained industry-leading performance despite a challenging agrochemical market, focusing on operational excellence, cost reduction, and efficiency improvements.

  • Major cost-saving initiatives and supply chain optimizations resulted in total savings of ¥635 million, with energy and procurement savings of ¥141 million and ¥253 million, respectively.

  • R&D investment reached ¥359 million, representing 3.44% of revenue, with 62 new invention patents granted.

  • The company proposed a cash dividend of ¥6.80 per 10 shares, totaling ¥276.55 million, subject to shareholder approval.

Financial highlights

  • Operating income: ¥10.43 billion, down 9.09% year-over-year.

  • Net profit attributable to shareholders: ¥1.20 billion, down 23.19% year-over-year.

  • Gross margin for agrochemicals: 23.44%, down 2.32 percentage points year-over-year.

  • Basic and diluted EPS: ¥2.978, down 23% year-over-year.

  • Net cash flow from operating activities: ¥2.16 billion, down 9.99% year-over-year.

  • Total assets: ¥17.66 billion, up 12.49% year-over-year.

Outlook and guidance

  • 2025 is expected to be highly challenging, with continued low product prices, overcapacity, and intensified competition.

  • The company will focus on market expansion, cost control, technological innovation, and project execution to drive growth.

  • Key risks include climate volatility, exchange rate fluctuations, market dependency, safety/environmental compliance, and geopolitical uncertainties.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more